Please assess the completion status of the following clinical trial:

Trial Title: NANOS Neck Preserving Hip Stem

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria:~* Patient requires Primary total hip replacement (THR) to the affected side, unilateral or bilateral. Bilateral only if \>3 months after the first THR~* Patient agreed to participate in the MCO study by signing the Informed Consent form.~* Age of patient at date of surgery 18 to 65 years~* Patient is likely to comply with study follow-up requirements~Exclusion criteria:~* Previously failed endoprosthesis and /or THR components in relevant hip~* Patient has proven osteoporosis~* Pronounced coxa valga with a femoral neck angle \> 145º~* Pronounced coxa vara with a femoral neck angle \< 125º~* History of infection in the affected joint; systemic infections~* Grossly insufficient femoral or acetabular bone stock in the involved hip where a revision cup is indicated~* Spinal disease with neurologic movement disorders~* Alcoholism or addictive disorders~* ASA score is 3 or 4~* Body mass index (BMI) \> 30~* Patient is pregnant or being pregnant during follow up intervals~* Patients understanding of the language is insufficient for understanding the Patient Information and Consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).